BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 23993451)

  • 1. Differential profiles of immune mediators and in vitro HIV infectivity between endocervical and vaginal secretions from women with Chlamydia trachomatis infection: a pilot study.
    Sperling R; Kraus TA; Ding J; Veretennikova A; Lorde-Rollins E; Singh T; Lo Y; Quayle AJ; Chang TL
    J Reprod Immunol; 2013 Sep; 99(1-2):80-7. PubMed ID: 23993451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlamydia trachomatis infection results in a modest pro-inflammatory cytokine response and a decrease in T cell chemokine secretion in human polarized endocervical epithelial cells.
    Buckner LR; Lewis ME; Greene SJ; Foster TP; Quayle AJ
    Cytokine; 2013 Aug; 63(2):151-65. PubMed ID: 23673287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diversity of Cervicovaginal Cytokine Response to Incident Chlamydia trachomatis Infection Among a Prospective Cohort of Young Women.
    Hwang LY; Scott ME; Ma Y; Moscicki AB
    Am J Reprod Immunol; 2015 Sep; 74(3):228-36. PubMed ID: 25989718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel whole-bacterial enzyme linked-immunosorbant assay to quantify Chlamydia trachomatis specific antibodies reveals distinct differences between systemic and genital compartments.
    Albritton HL; Kozlowski PA; Lillis RA; McGowin CL; Siren JD; Taylor SN; Ibana JA; Buckner LR; Shen L; Quayle AJ
    PLoS One; 2017; 12(8):e0183101. PubMed ID: 28797112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina.
    Mostad SB; Overbaugh J; DeVange DM; Welch MJ; Chohan B; Mandaliya K; Nyange P; Martin HL; Ndinya-Achola J; Bwayo JJ; Kreiss JK
    Lancet; 1997 Sep; 350(9082):922-7. PubMed ID: 9314871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A distinct cellular profile is seen in the human endocervix during Chlamydia trachomatis infection.
    Ficarra M; Ibana JS; Poretta C; Ma L; Myers L; Taylor SN; Greene S; Smith B; Hagensee M; Martin DH; Quayle AJ
    Am J Reprod Immunol; 2008 Nov; 60(5):415-25. PubMed ID: 18798835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators.
    Dezzutti CS; Hendrix CW; Marrazzo JM; Pan Z; Wang L; Louissaint N; Kalyoussef S; Torres NM; Hladik F; Parikh U; Mellors J; Hillier SL; Herold BC
    PLoS One; 2011; 6(8):e23136. PubMed ID: 21858008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysbiosis of the Vaginal Microbiota and Higher Vaginal Kynurenine/Tryptophan Ratio Reveals an Association with
    Ziklo N; Vidgen ME; Taing K; Huston WM; Timms P
    Front Cell Infect Microbiol; 2018; 8():1. PubMed ID: 29404279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metagenomic Shotgun Sequencing of Endocervical, Vaginal, and Rectal Samples among Fijian Women with and without Chlamydia trachomatis Reveals Disparate Microbial Populations and Function across Anatomic Sites: a Pilot Study.
    Bommana S; Richards G; Kama M; Kodimerla R; Jijakli K; Read TD; Dean D
    Microbiol Spectr; 2022 Jun; 10(3):e0010522. PubMed ID: 35579443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine expression pattern in the genital tract of Chlamydia trachomatis positive infertile women - implication for T-cell responses.
    Reddy BS; Rastogi S; Das B; Salhan S; Verma S; Mittal A
    Clin Exp Immunol; 2004 Sep; 137(3):552-8. PubMed ID: 15320905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical Cytokines Associated With Chlamydia trachomatis Susceptibility and Protection.
    Poston TB; Lee DE; Darville T; Zhong W; Dong L; O'Connell CM; Wiesenfeld HC; Hillier SL; Sempowski GD; Zheng X
    J Infect Dis; 2019 Jun; 220(2):330-339. PubMed ID: 30820577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone activates multiple innate immune pathways in Chlamydia trachomatis-infected endocervical cells.
    Wan C; Latter JL; Amirshahi A; Symonds I; Finnie J; Bowden N; Scott RJ; Cunningham KA; Timms P; Beagley KW
    Am J Reprod Immunol; 2014 Feb; 71(2):165-77. PubMed ID: 24206234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased interleukin-10 in the the endocervical secretions of women with non-ulcerative sexually transmitted diseases: a mechanism for enhanced HIV-1 transmission?
    Cohen CR; Plummer FA; Mugo N; Maclean I; Shen C; Bukusi EA; Irungu E; Sinei S; Bwayo J; Brunham RC
    AIDS; 1999 Feb; 13(3):327-32. PubMed ID: 10199222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential mechanisms for increased HIV-1 transmission across the endocervical epithelium during C. trachomatis infection.
    Schust DJ; Ibana JA; Buckner LR; Ficarra M; Sugimoto J; Amedee AM; Quayle AJ
    Curr HIV Res; 2012 Apr; 10(3):218-27. PubMed ID: 22384841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract.
    Rebbapragada A; Wachihi C; Pettengell C; Sunderji S; Huibner S; Jaoko W; Ball B; Fowke K; Mazzulli T; Plummer FA; Kaul R
    AIDS; 2007 Mar; 21(5):589-98. PubMed ID: 17314521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of pregnancy on anti-HIV activity of cervicovaginal secretions.
    Hughes BL; Dutt R; Raker C; Barthelemy M; Rossoll RM; Ramratnam B; Wira CR; Cu-Uvin S
    Am J Obstet Gynecol; 2016 Dec; 215(6):748.e1-748.e12. PubMed ID: 27393267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocervical and vaginal microbiota in South African adolescents with asymptomatic Chlamydia trachomatis infection.
    Balle C; Lennard K; Dabee S; Barnabas SL; Jaumdally SZ; Gasper MA; Maseko V; Mbulawa ZZA; Williamson AL; Bekker LG; Lewis DA; Passmore JS; Jaspan HB
    Sci Rep; 2018 Jul; 8(1):11109. PubMed ID: 30038262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the tryptophan-indole-IFNγ axis on human genital Chlamydia trachomatis infection: role of vaginal co-infections.
    Aiyar A; Quayle AJ; Buckner LR; Sherchand SP; Chang TL; Zea AH; Martin DH; Belland RJ
    Front Cell Infect Microbiol; 2014; 4():72. PubMed ID: 24918090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro anti-HIV-1 activity in cervicovaginal secretions from pregnant and nonpregnant women.
    Anderson BL; Ghosh M; Raker C; Fahey J; Song Y; Rouse DJ; Wira CR; Cu-Uvin S
    Am J Obstet Gynecol; 2012 Jul; 207(1):65.e1-10. PubMed ID: 22727351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection.
    Dabee S; Barnabas SL; Lennard KS; Jaumdally SZ; Gamieldien H; Balle C; Happel AU; Murugan BD; Williamson AL; Mkhize N; Dietrich J; Lewis DA; Chiodi F; Hope TJ; Shattock R; Gray G; Bekker LG; Jaspan HB; Passmore JS
    PLoS One; 2019; 14(4):e0213975. PubMed ID: 30947260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.